BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer.
Lack of reliable predictive biomarkers is a stumbling block in the management of prostate cancer (CaP). Prostate-specific antigen (PSA) widely used in clinics has several caveats as a CaP biomarker. African-American CaP patients have poor prognosis than Caucasians, and notably the serum-PSA does not...
Main Authors: | Hifzur Rahman Siddique, Aijaz Parray, Weixiong Zhong, R Jeffery Karnes, Eric J Bergstralh, Shahriar Koochekpour, Johng S Rhim, Badrinath R Konety, Mohammad Saleem |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3538726?pdf=render |
Similar Items
-
Correction: BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer.
by: Hifzur Rahman Siddique, et al.
Published: (2013-01-01) -
BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.
by: Hifzur Rahman Siddique, et al.
Published: (2013-01-01) -
Correction: BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer
Published: (2013-01-01) -
Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression
by: Arsheed A. Ganaie, et al.
Published: (2019-08-01) -
Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
by: Shahriar Koochekpour, et al.
Published: (2013-01-01)